Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F1F78
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,032
Award facts
- Contract value 100% obligated
- $41,032.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,032.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count units of RINVOQ ER 30 mg tablets, with an ultimate completion date of November 6, 2025. This non-set-aside competitive award was issued on November 5, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the vehicle enabling this delivery order and numerous other pharmaceutical supply missions across federal healthcare systems.
This delivery order represents a routine pharmaceutical procurement under the DLA's Medical Supply Chain, supporting the agency's mission to provide critical medications to military and veteran healthcare systems. RINVOQ ER is a prescription immunosuppressant medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. As a prime contractor on the DLA Troop Support Medical IDC, AmerisourceBergen Drug Corp consistently fulfills federal medical procurement requirements through competitive awards, leveraging its extensive portfolio of brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F1F78?
SPE2DR26F1F78 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F1F78 worth?
The government has obligated $41,032 on SPE2DR26F1F78.
Is contract SPE2DR26F1F78 an order under another contract?
Yes. SPE2DR26F1F78 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1F78 competed?
The extent of competition for SPE2DR26F1F78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award